Connect Biopharma(CNTB)
Focus: Connect Biopharma is a public immunology-focused biopharmaceutical company developing treatments for autoimmune diseases and inflammation, headquartered in San Diego with a lean operational footprint.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
5
Should You Work at Connect Biopharma?
AI assessmentSuitable for immunology specialists seeking Phase 2/3 exposure in autoimmune disease with manageable cash-runway risk, but limited headcount growth.
Why Work Here
- Focused immunology pipeline with CBP-201 in Phase 3 for atopic dermatitis and multiple Phase 2 programs in high-unmet-need areas (asthma, ulcerative colitis, chronic rhinosinusitis)
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$26M
Key Products
Peak
Multiple peak-stage NDA entries suggest mature, revenue-generating utility product.
Help build intelligence for Connect Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.